Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study

Prostate. 2004 Jun 1;59(4):357-9. doi: 10.1002/pros.20005.

Abstract

Background: Serine proteases play an important role in prostate cancer (PCa) invasion through the degradation of extracellular matrix proteins and interaction with growth modulating factors. The transmembrane serine protease 2 (TMPRSS2) gene encodes a type II transmembrane protein which, due to its cell surface localization, could be a potentially useful predictive marker for PCa.

Methods: We screened a population of 24 unrelated individuals for sequence variants in the TMPRSS2 gene, and found a Met160Val change in 33%. We then tested 559 cases and 523 controls from a population-based case-control study of middle-aged men from Washington State.

Results: Men with the GG genotype and a first-degree family history of PCa had a significantly higher risk for PCa relative to men without a family history (OR = 2.05; 95% CI = 1.3-3.2). However, the interaction between genotype and family history of PCa was not significant (P = 0.52).

Conclusions: Larger, more detailed studies are needed to fully investigate the role of serine proteases in PCa.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Case-Control Studies
  • Genetic Markers*
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Pedigree
  • Polymorphism, Genetic*
  • Prostatic Neoplasms / genetics*
  • Risk Factors
  • Serine Endopeptidases / genetics*

Substances

  • Genetic Markers
  • Serine Endopeptidases
  • TMPRSS2 protein, human